3-38760760-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006514.4(SCN10A):​c.884-13T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.295 in 1,605,174 control chromosomes in the GnomAD database, including 74,792 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 7964 hom., cov: 32)
Exomes 𝑓: 0.29 ( 66828 hom. )

Consequence

SCN10A
NM_006514.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.17

Publications

11 publications found
Variant links:
Genes affected
SCN10A (HGNC:10582): (sodium voltage-gated channel alpha subunit 10) The protein encoded by this gene is a tetrodotoxin-resistant voltage-gated sodium channel alpha subunit. The properties of the channel formed by the encoded transmembrane protein can be altered by interaction with different beta subunits. This protein may be involved in the onset of pain associated with peripheral neuropathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
SCN10A Gene-Disease associations (from GenCC):
  • sodium channelopathy-related small fiber neuropathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • episodic pain syndrome, familial, 2
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
  • Brugada syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 3-38760760-A-G is Benign according to our data. Variant chr3-38760760-A-G is described in ClinVar as Benign. ClinVar VariationId is 260000.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.669 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN10ANM_006514.4 linkc.884-13T>C intron_variant Intron 7 of 27 ENST00000449082.3 NP_006505.4 Q9Y5Y9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN10AENST00000449082.3 linkc.884-13T>C intron_variant Intron 7 of 27 1 NM_006514.4 ENSP00000390600.2 Q9Y5Y9
SCN10AENST00000643924.1 linkc.884-13T>C intron_variant Intron 6 of 26 ENSP00000495595.1 A0A2R8Y6J6
SCN10AENST00000655275.1 linkc.914-16T>C intron_variant Intron 7 of 27 ENSP00000499510.1 A0A590UJM0

Frequencies

GnomAD3 genomes
AF:
0.315
AC:
47846
AN:
151970
Hom.:
7948
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.337
Gnomad AMI
AF:
0.371
Gnomad AMR
AF:
0.297
Gnomad ASJ
AF:
0.373
Gnomad EAS
AF:
0.687
Gnomad SAS
AF:
0.368
Gnomad FIN
AF:
0.268
Gnomad MID
AF:
0.275
Gnomad NFE
AF:
0.277
Gnomad OTH
AF:
0.304
GnomAD2 exomes
AF:
0.327
AC:
81671
AN:
249692
AF XY:
0.326
show subpopulations
Gnomad AFR exome
AF:
0.348
Gnomad AMR exome
AF:
0.291
Gnomad ASJ exome
AF:
0.372
Gnomad EAS exome
AF:
0.687
Gnomad FIN exome
AF:
0.268
Gnomad NFE exome
AF:
0.278
Gnomad OTH exome
AF:
0.301
GnomAD4 exome
AF:
0.293
AC:
425567
AN:
1453086
Hom.:
66828
Cov.:
30
AF XY:
0.295
AC XY:
213118
AN XY:
723482
show subpopulations
African (AFR)
AF:
0.355
AC:
11810
AN:
33278
American (AMR)
AF:
0.296
AC:
13243
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.368
AC:
9590
AN:
26074
East Asian (EAS)
AF:
0.693
AC:
27476
AN:
39632
South Asian (SAS)
AF:
0.359
AC:
30860
AN:
86064
European-Finnish (FIN)
AF:
0.270
AC:
14410
AN:
53272
Middle Eastern (MID)
AF:
0.287
AC:
1650
AN:
5748
European-Non Finnish (NFE)
AF:
0.270
AC:
298013
AN:
1104244
Other (OTH)
AF:
0.308
AC:
18515
AN:
60078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
13038
26076
39114
52152
65190
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10224
20448
30672
40896
51120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.315
AC:
47915
AN:
152088
Hom.:
7964
Cov.:
32
AF XY:
0.318
AC XY:
23667
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.338
AC:
13998
AN:
41474
American (AMR)
AF:
0.298
AC:
4551
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.373
AC:
1295
AN:
3470
East Asian (EAS)
AF:
0.688
AC:
3554
AN:
5168
South Asian (SAS)
AF:
0.370
AC:
1781
AN:
4808
European-Finnish (FIN)
AF:
0.268
AC:
2831
AN:
10582
Middle Eastern (MID)
AF:
0.272
AC:
80
AN:
294
European-Non Finnish (NFE)
AF:
0.277
AC:
18847
AN:
67976
Other (OTH)
AF:
0.303
AC:
641
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1645
3291
4936
6582
8227
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
484
968
1452
1936
2420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.291
Hom.:
22991
Bravo
AF:
0.319
Asia WGS
AF:
0.492
AC:
1712
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 04, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 21, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Episodic pain syndrome, familial, 2 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Brugada syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
12
DANN
Benign
0.86
PhyloP100
1.2
Mutation Taster
=74/26
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7641844; hg19: chr3-38802251; COSMIC: COSV71861141; API